Zilebesiran
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Zilebesiran, covering 2025-07-09 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease [Phase 3]